New evidence connects age to systemic therapy outcomes in metastatic prostate cancer When doctors assemble a treatment plan for metastatic prostate cancer, they weigh tumor biology, disease burden, patient health, and functional status. A recent study, published in the October 28, 2025 edition of an esteemed medical journal, adds another factor to the decision-making toolkit:…